KVUE | tickerfilter.com

Fundamental analysis

80%

Profitability 88%

Dept financing 45%

Liquidity 44%

Performance 90%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-1.36%

1 Month

-9.63%

3 Months

-5.43%

6 Months

17.49%

1 Year

2.59%

2 Year

-19.07%

Key data

Stock price

$23.20

P/E Ratio

33.42

DAY RANGE

$21.57 - $23.20

EPS

$0.65

52 WEEK RANGE

$17.94 - $24.46

52 WEEK CHANGE

$1.92

MARKET CAP

42.038 B

YIELD

3.61%

SHARES OUTSTANDING

1.915 B

DIVIDEND

$0.205

EX-DIVIDEND DATE

08/14/2024

NEXT EARNINGS DATE

10/31/2024

BETA

0.68

PUBLIC FLOAT

AVERAGE 10 VOLUME

$12,858,560

AVERAGE 30 VOLUME

$13,362,826

Company detail

CEO: Thibaut Mongon
Region: US
Website: www.jnj.com/kenvue/
Employees: 0
IPO year: -

Issue type: Common Stock
Market: NYSE
Industry: Toilet Preparation Manufacturing
Sector: Manufacturing

We are the world’s largest pure-play consumer health company by revenue with $15.0 billion in net sales in 2022. We combine the power of science with meaningful human insights and digital-first capabilities, which we believe empowers approximately 1.2 billion people to live healthier lives every day. Prior to the completion of this offering, we are a wholly owned subsidiary of Johnson & Johnson. Our principal executive offices are located at 199 Grandview Road, Skillman, NJ.

KVUE - Kenvue Inc.